ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) Investor Lawsuit Deadline on February 26
A deadline is coming up on February 26, 2013in the lawsuit filed for investors of ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) over alleged securities laws violations by ISIS Pharmaceuticals in connection with in connection certain allegedly false and misleading statements over its drug Kynamro.
View full press release